CTRI/2017/02/007970已完成1 期
Management of Artava Dushti w.s.r to Polycystic Ovarian Syndrome with Virechana and Pathadi Kwatha â?? A randomized controlled clinical trial
IPGT RA GAU Jamnagar Gujarat0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Amenorrhoea or Oligomenorrhoea, Anovulatory infertility, Acne, Hirsutism, Obesity, Acanthosis nigricans.
排除标准
- •Patients suffering from Pelvic/Systemic diseases like( Endometriosis, Hydrosalphinx, Fibroid uterus) causing Oligomenorrhoea and Anovulation.Organic lesions of reproductive tract like T.B, Carcinoma and Congenital deformities,uncontrolled Hypertension, uncontrolled Diabetes Mellitus, Hepatic/Renal disease, Cushingâ??s syndrome, Cardiac diseases, Age group <18 yrs and > 40 yrs
研究者
相似试验
尚未招募
3 期
MANAGEMENT OF ARTAVA DUSHTI W.S.R TO POLYCYSTIC OVARIAN SYNDROME WITH AROGYAVARDHINI RASA AND PATHADI CHOORNA.CTRI/2021/02/030954IPGT AND RA
招募中
1 期
Management of delayed menstural cycle (PCOS)CTRI/2018/09/015857ational Institute Of Ayurveda
已完成
不适用
Management of anovulation associated with polycystic ovarian syndrome: a randomised trial of clomid versus clomid plus metformin.ISRCTN77388772Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
已完成
2 期
An observational study to evaluate the status of Dhatu Sarata in Polycystic Ovary DiseaseCTRI/2022/09/045466Dean Faculty of Ayurved Parul University100
已完成
不适用
EFFECT OF DRUG NISHAMLAKI IN PCOSCTRI/2017/07/009111Pharmaza Herbals Pvt Ltd24